Skip to content

Released Aug 13, 2025, before the open

10-Q filed Aug 13, 2025, 44 days after period end · 0000868278-25-000011

Q2 2025 · 10-Q
Revenue$1.25M−17.1% vs Q2 2024−12.9% vs Q1 2025
Net Income-$4.47MN/M vs Q2 2024N/M vs Q1 2025
EPS Diluted-$1.08N/M vs Q2 2024N/M vs Q1 2025
Gross Profit$734,000N/M
Operating Income-$3,894,000N/M
Operating Cash Flowderived-$247,000N/M
Free Cash Flowderived-$247,000N/M
Margins · derived
Gross margin58.9%+69.2 pt vs Q2 2024
Operating margin-312.3%+168.3 pt vs Q2 2024
Net margin-358.6%+50.5 pt vs Q2 2024

What the release said

The release

Same quarter

MetricQ2 2025Q2 2024Q2 2023Q2 2022
Revenue$1.25M$1.50M$13.22M$29.09M
Net Income-$4.47M-$6.15M-$3.44M$7.45M
EPS Diluted-$1.08-$0.33-$0.20$0.40

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR